The case of the vanishing brain tumor
The brain is a new frontier for cancer immunotherapy
The brain is a new frontier for cancer immunotherapy
Excerpts from 'The Puzzle Solver'
Anti-CD47 cancer treatment has been found to help atherosclerosis
Keeping joint movement pain-free
A sampler of COVID-19 research
Stanford launched its own test early in the pandemic — but the challenges kept on coming
Ulcerative colitis patients could be missing a key intestinal microbe
Stanford researchers stand at the forefront of efforts to defeat the disease
The experimental drug filgotinib blocks a set of enzymes that cause inflammation in rheumatoid arthritis patients who haven’t benefitted from other treatments, a study shows.
Stimulating cells that jump in to protect healthy tissues in MS patients when their immune systems attack could lead to new drug therapies, researcher says.